{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:47:28Z","timestamp":1790009248771,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":1810,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Koningin Wilhelmina Fonds","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004622","name":"The Dutch Cancer Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jmoldx.2014.09.005","type":"journal-article","created":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T11:56:32Z","timestamp":1414151792000},"page":"43-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Whole-Genome Sequencing Identifies Patient-Specific DNA Minimal Residual Disease Markers in Neuroblastoma"],"prefix":"10.1016","volume":"17","author":[{"given":"Esther M.","family":"van Wezel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Zwijnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Zappeij-Kannegieter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Bus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max M.","family":"van Noesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Molenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier","family":"Versteeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Fiocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huib N.","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ellen","family":"van der Schoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Koster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godelieve A.M.","family":"Tytgat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2014.09.005_bib1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00043426-199709000-00004","article-title":"Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992","volume":"19","author":"Gurney","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00043426-199703000-00001","article-title":"Biology and genetics of human neuroblastomas","volume":"19","author":"Brodeur","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib3","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma","volume":"369","author":"Maris","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib4","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/sj.bjc.6605014","article-title":"International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee","volume":"100","author":"Ambros","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib5","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib6","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1373\/clinchem.2008.117945","article-title":"Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers","volume":"55","author":"Stutterheim","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib7","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/sj.bjc.6605029","article-title":"Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force","volume":"100","author":"Beiske","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib8","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1200\/JCO.2007.13.6531","article-title":"PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma","volume":"26","author":"Stutterheim","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jmoldx.2011.12.002","article-title":"Stability of PCR targets for monitoring minimal residual disease in neuroblastoma","volume":"14","author":"Stutterheim","year":"2012","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib10","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1158\/1078-0432.CCR-11-0849","article-title":"Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma","volume":"18","author":"Stutterheim","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nature10910","article-title":"Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes","volume":"483","author":"Molenaar","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10825","article-title":"Clonal selection drives genetic divergence of metastatic medulloblastoma","volume":"482","author":"Wu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1054\/bjoc.2001.1849","article-title":"Genetic heterogeneity and clonal evolution in neuroblastoma","volume":"85","author":"Mora","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib14","first-page":"105","article-title":"Tumor heterogeneity: causes and consequences","volume":"1805","author":"Marusyk","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib15","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature10738","article-title":"Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib16","doi-asserted-by":"crossref","first-page":"11471","DOI":"10.1158\/0008-5472.CAN-07-2496","article-title":"Clonal selection of metastasis within the life history of a tumor","volume":"67","author":"Talmadge","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ejca.2008.01.010","article-title":"Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age","volume":"44","author":"de Kraker","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib18","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/0959-8049(92)90062-7","article-title":"High-dose rapid schedule chemotherapy for disseminated neuroblastoma","volume":"28A","author":"Pearson","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.1181498","article-title":"Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays","volume":"327","author":"Drmanac","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib20","first-page":"391","article-title":"An efficient salt-chloroform extraction of DNA from blood and tissues","volume":"5","author":"Mullenbach","year":"1989","journal-title":"Trends Genet"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.leu.2404586","article-title":"Analysis of minimal residual disease by Ig\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data","volume":"21","author":"van der Velden","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1056\/NEJMc1306040","article-title":"Circulating tumor DNA to monitor metastatic breast cancer","volume":"369","author":"Dawson","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib23","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/gcc.20815","article-title":"Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors","volume":"49","author":"McBride","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib24","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia","volume":"341","author":"Faderl","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1056\/NEJM199408043310503","article-title":"The Ewing family of tumors\u2013a subgroup of small-round-cell tumors defined by specific chimeric transcripts","volume":"331","author":"Delattre","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib27","first-page":"1063","article-title":"MYCN amplicon junctions as tumor-specific targets for minimal residual disease detection in neuroblastoma","volume":"39","author":"Kryh","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib28","doi-asserted-by":"crossref","first-page":"e3099","DOI":"10.1371\/journal.pone.0003099","article-title":"Binomial mitotic segregation of MYCN-carrying double minutes in neuroblastoma illustrates the role of randomness in oncogene amplification","volume":"3","author":"Lundberg","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib29","first-page":"1597","article-title":"Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer","volume":"57","author":"Kuukasjarvi","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9440(10)65120-6","article-title":"Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization","volume":"155","author":"Bissig","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib31","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1158\/1078-0432.CCR-06-0444","article-title":"Clonal origin of metastatic testicular teratomas","volume":"12","author":"Jones","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib32","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/nrc2013","article-title":"Cancer as an evolutionary and ecological process","volume":"6","author":"Merlo","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1200\/JCO.1986.4.3.363","article-title":"Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies","volume":"4","author":"Cheung","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib34","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ejca.2011.02.003","article-title":"The prognostic value of fast molecular response of marrow disease in patients aged over 1 year with stage 4 neuroblastoma","volume":"47","author":"Stutterheim","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11684-012-0182-x","article-title":"Exploring the cancer genome in the era of next-generation sequencing","volume":"6","author":"Dong","year":"2012","journal-title":"Front Med"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1309\/AJCPR1SVT1VHUGXW","article-title":"Whole cancer genome sequencing by next-generation methods","volume":"136","author":"Ross","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/asheducation-2011.1.30","article-title":"Genomics of AML: clinical applications of next-generation sequencing","volume":"2011","author":"Welch","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib38","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/1078-0432.CCR-10-0830","article-title":"A multilocus technique for risk evaluation of patients with neuroblastoma","volume":"17","author":"Ambros","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib39","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1158\/1078-0432.CCR-11-1409","article-title":"New strategies in refractory and recurrent neuroblastoma: translational opportunities to impact patient outcome","volume":"18","author":"Cole","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib40","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.2012.228","article-title":"Association of age at diagnosis and genetic mutations in patients with neuroblastoma","volume":"307","author":"Cheung","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ng.2529","article-title":"The genetic landscape of high-risk neuroblastoma","volume":"45","author":"Pugh","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2014.09.005_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/ng.2493","article-title":"Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma","volume":"45","author":"Sausen","year":"2013","journal-title":"Nat Genet"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157814001792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157814001792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T11:03:40Z","timestamp":1589281420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157814001792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1525157814001792"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2014.09.005","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole-Genome Sequencing Identifies Patient-Specific DNA Minimal Residual Disease Markers in Neuroblastoma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2014.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}